PMC:7402624 / 30586-30820 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T263","span":{"begin":21,"end":25},"obj":"Body_part"},{"id":"T264","span":{"begin":134,"end":141},"obj":"Body_part"},{"id":"T265","span":{"begin":150,"end":153},"obj":"Body_part"},{"id":"T266","span":{"begin":162,"end":165},"obj":"Body_part"},{"id":"T267","span":{"begin":173,"end":181},"obj":"Body_part"},{"id":"T268","span":{"begin":212,"end":214},"obj":"Body_part"}],"attributes":[{"id":"A263","pred":"fma_id","subj":"T263","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A264","pred":"fma_id","subj":"T264","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A265","pred":"fma_id","subj":"T265","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A266","pred":"fma_id","subj":"T266","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A267","pred":"fma_id","subj":"T267","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A268","pred":"fma_id","subj":"T268","obj":"http://purl.org/sig/ont/fma/fma84371"}],"text":"the equivalent CD8 T cell populations (fig. S5E). Although ~70% of COVID-19 patients analyzed made antibodies against SARS-CoV2 spike protein (79/111 IgG; 77/115 IgM (44)), antibody levels did not correlate with PB frequencies (Fig. 4"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1105","span":{"begin":15,"end":18},"obj":"Gene"},{"id":"1109","span":{"begin":76,"end":84},"obj":"Species"},{"id":"1110","span":{"begin":118,"end":127},"obj":"Species"},{"id":"1130","span":{"begin":67,"end":75},"obj":"Disease"}],"attributes":[{"id":"A1105","pred":"tao:has_database_id","subj":"1105","obj":"Gene:925"},{"id":"A1109","pred":"tao:has_database_id","subj":"1109","obj":"Tax:9606"},{"id":"A1110","pred":"tao:has_database_id","subj":"1110","obj":"Tax:2697049"},{"id":"A1130","pred":"tao:has_database_id","subj":"1130","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"the equivalent CD8 T cell populations (fig. S5E). Although ~70% of COVID-19 patients analyzed made antibodies against SARS-CoV2 spike protein (79/111 IgG; 77/115 IgM (44)), antibody levels did not correlate with PB frequencies (Fig. 4"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T237","span":{"begin":67,"end":75},"obj":"Disease"},{"id":"T238","span":{"begin":118,"end":122},"obj":"Disease"},{"id":"T239","span":{"begin":212,"end":214},"obj":"Disease"}],"attributes":[{"id":"A237","pred":"mondo_id","subj":"T237","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A238","pred":"mondo_id","subj":"T238","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A239","pred":"mondo_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/MONDO_0019035"}],"text":"the equivalent CD8 T cell populations (fig. S5E). Although ~70% of COVID-19 patients analyzed made antibodies against SARS-CoV2 spike protein (79/111 IgG; 77/115 IgM (44)), antibody levels did not correlate with PB frequencies (Fig. 4"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T526","span":{"begin":15,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T527","span":{"begin":19,"end":25},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"the equivalent CD8 T cell populations (fig. S5E). Although ~70% of COVID-19 patients analyzed made antibodies against SARS-CoV2 spike protein (79/111 IgG; 77/115 IgM (44)), antibody levels did not correlate with PB frequencies (Fig. 4"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T215","span":{"begin":134,"end":141},"obj":"Chemical"},{"id":"T216","span":{"begin":212,"end":214},"obj":"Chemical"}],"attributes":[{"id":"A215","pred":"chebi_id","subj":"T215","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A216","pred":"chebi_id","subj":"T216","obj":"http://purl.obolibrary.org/obo/CHEBI_53319"},{"id":"A217","pred":"chebi_id","subj":"T216","obj":"http://purl.obolibrary.org/obo/CHEBI_60686"}],"text":"the equivalent CD8 T cell populations (fig. S5E). Although ~70% of COVID-19 patients analyzed made antibodies against SARS-CoV2 spike protein (79/111 IgG; 77/115 IgM (44)), antibody levels did not correlate with PB frequencies (Fig. 4"}